Phase 2 Study of Pegylated Liposomal Doxorubicin, Vincristine, Decreased-Frequency Dexamethasone, and Thalidomide in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma
Year: 2006
Type: article
Study design: Clinical Trial
Source: Mayo Clinic Proceedings
DOI: 10.4065/81.7.889
Institutions: Cleveland Clinic, Sparrow Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2016038211
